OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy (Q2866833): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en, pt: Fixing missing labels.) |
(Removed claim: co-financing rate (P837): 74.63 percentage) |
||||||
Property / co-financing rate | |||||||
| |||||||
Property / co-financing rate: 74.63 percent / rank | |||||||
Revision as of 22:24, 8 November 2022
Project Q2866833 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy |
Project Q2866833 in Portugal |
Statements
349,140.0 Euro
0 references
467,816.0 Euro
0 references
1 March 2016
0 references
1 March 2018
0 references
HEARTGENETICS GENETICS AND BIOTECHNOLOGY, S.A.
0 references
Cantanhede
0 references
Identifiers
CENTRO-01-0247-FEDER-010500
0 references